| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V51483 | Clivatuzumab | 1622075-09-5 | Clivatuzumab is a humanized anti-mucin monoclonal antibody (mAb) that targets the MUC1 epitope expressed in most pancreatic cancers. |
|
V75087 | Gatipotuzumab (PankoMab) | 1264737-26-9 | Gatipotuzumab (PankoMab) is a humanized monoclonal antibody (mAb) that recognizes the tumor-specific epitope of mucin-1 (TA-MUC1). |
|
V80660 | MA3 aptamer sodium | MA3 aptamer sodium is an 86-base DNA aptamer targeting the mucin MUC1. | |
|
V75090 | MUC1, mucin core | 149205-73-2 | MUC1, mucin core is the region of the MUC1 mucin core. |
|
V75089 | MUC5AC motif peptide (MUC5AC motif peptide) | 244049-41-0 | The MUC5AC motif peptide is a 16-amino acid (AA) fragment of mucin 5. |
|
V81343 | S2.2 aptamer sodium | S2.2 aptamer sodium is a nucleic acid aptamer targeting the mucin MUC1 and can be used for targeted imaging of MCF-7 cancer cells. | |
|
V76463 | Surzebiclimab (BGB-A425) | Surzebiclimab (BGB-A425) is a humanized IgG1 variant monoclonal antibody (mAb) directed against T-cell immunoglobulin and mucin domain-containing 3 (TIM-3). |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
